A woman's fertility decreases as she ages, but the exact age when a woman can no longer conceive varies from woman to woman. Women of the same age can have different ovarian reserves, and thus their likelihood of getting pregnant also varies —one may conceive very easily, while the other may not.
While there is no straightforward answer to questions regarding the absolute limit of female fertility, there are indicators that can provide an estimate. A woman's ovarian reserve predicts her fertility potential in the absence of any other problems in the reproductive tract (fallopian tubes, uterus, and vagina).
Why measure ovarian reserve?
Ovarian reserve provides an estimate of the number and quality of remaining eggs in a woman, and how well the ovarian follicles are responding to the hormonal signals from the brain. There are a number of tests known as ovarian reserve tests (ORTs), have been developed to help predict ovarian reserve and thus reproductive potential.
ORTs are used for a variety of reasons:
- To decide on whether pregnancy can be delayed; and if yes, for how long. This is all the more relevant a reason since the availability of effective egg and embryo freezing techniques.
- Along with other tests, ORTs help in the diagnosis of conditions like menopause, premature ovarian failure, and polycystic ovary syndrome (PCOS).
- Ovarian reserve testing adds more prognostic information (that which could predict the likely course of the condition) to the counseling and planning process to help women and their partners choose the best treatment option. Clinicians use this information along with factors including age and diagnoses to counsel individual patients and tailor a treatment plan, including the appropriate drugs and dosages.
It is important to emphasize that ovarian reserve tests are only estimates. Evidence of decreased ovarian reserve does not necessarily mean the inability to conceive.
Ovarian Reserve Tests
Ovarian reserve tests (ORTs) are markers that provide an estimate of a woman's remaining pool of eggs. These tests also provide, to some extent, information on egg quality.
One common way to test ovarian reserve is by measuring hormone blood levels. However, it is important to keep in mind that laboratory procedures and “normal” levels vary from lab to lab. It can be difficult to compare results from one laboratory to another.
Follicle-stimulating Hormone Test
Follicle-stimulating hormone (FSH) and estradiol levels are tested by measuring blood levels at the start of the menstrual cycle. This is usually done on cycle day 3, but it can be drawn from day 1 to 5. These hormone levels can show important information about how the ovaries and pituitary gland are working together.
Anti-mullerian hormone (AMH) test is another test of ovarian reserve that measures the levels of AMH in blood levels. AMH is a hormone made in the follicle and is related to the number of eggs. The advantage of AMH testing is that blood can be drawn at any time during the menstrual cycle and is not limited to menstrual cycle days 1 to 5.
Clomiphene Citrate Challenge Test
The Clomiphene citrate challenge test involves taking an ovulatory stimulant called clomiphene citrate early in the menstrual cycle to see how the ovaries respond. Blood levels of FSH and estradiol are measured before and FSH is measured after clomiphene citrate is given.
Women with high FSH levels either before or after the medication, have lower pregnancy rates with any assisted reproduction treatment.
Ultrasound assessments of the ovaries and uterus can also provide information to help determine ovarian reserve. This includes the antral follicle count (AFC), the ovarian volume and blood flow, and some uterine dimensions.
Antral follicles are the small (2mm-10mm) follicles in the ovary where eggs start to develop. A transvaginal ultrasound may be done in the early part of the menstrual cycle to count the number of antral follicles. This number can provide an estimate of how many eggs are available and can indicate a woman’s expected response to gonadotropin medicines that are used in assisted reproductive technology.
Diminished Ovarian Reserve
Diminished ovarian reserve, also known as primary ovarian insufficiency, decreased ovarian reserve, or diminished ovarian reserve (DOR), describes women of reproductive age who have a regular menstrual cycle, but whose natural ability to become pregnant or to response to ovarian stimulation during assisted reproductive treatments is reduced when compared to women of a similar age.
Signs of Diminished Ovarian Reserve
Diminished ovarian reserve is distinct from menopause or premature ovarian failure. There may or may not be any symptoms. Difficulty getting pregnant may be the earliest and only sign.
Diminished Ovarian Reserve and Age
A woman is born with all the eggs that she will have in her lifetime. These eggs get depleted with age, both due to the fact that they get mature and are released during ovulation, and also due to a simultaneously occurring process of cell atresia, in which for every egg that is ovulated, others are also depleted. This is why later life women have fewer eggs, egg quality decreases due to aging, and eggs have more abnormalities in their chromosomes (genetic material). All these factors combined contribute to why older women have lower pregnancy rates and higher miscarriage rates.
Factors Affecting Ovarian reserve
Age is the main factor that affects ovarian reserve in all women. However, there are other factors that adversely affect ovarian reserve in some women. These include:
- Exposure to systemic chemotherapy
- Pelvic irradiation
- Genetic abnormalities
- Lifestyle behaviors like cigarette smoking
Can diminished ovarian reserve be treated?
Unfortunately, there is no treatment for low ovarian reserve. Ovarian aging is irreversible. Once eggs have been depleted, there is no way to generate new eggs. Hormonal therapy (consisting of estrogen and progesterone) and a number of non-hormonal therapies can be used to treat symptoms, but will not help with fertility
For women with low ovarian reserve who are want to become pregnant, assisted reproductive technologies with the experimental use of allied medications e.g. growth hormone, are used in an attempt to improve the number of eggs retrieved by ovarian stimulation. Optimizing weight, diet and stress and cessation of use of tobacco, alcohol and recreational substances can also be tried in an attempt to improve response to ovarian stimulation. The use of an egg donor is an additional possibility.